来自质子疗法中心的三年见解:在表皮瘤治疗规划中发展战略
Lieselotte Lauwens1,2, Anneleen Goedgebeur2,3, Tom Boterberg3,4
1KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Belgium.
Technical innovations & patient support in radiation oncology
|October 28, 2025
概括
一种混合质子-光子 (PT-XT) 方法用于后腔膜瘤提供了一个可行的治疗选择. 这种方法表明可接受的大脑干剂量,在选定的患者中没有症状的大脑干损伤.
科学领域:
- 辐射瘤学 辐射瘤学
- 儿科神经瘤学 儿童神经瘤学
- 医学物理 医学物理
背景情况:
- 用质子疗法 (PT) 治疗后腔膜瘤是具有挑战性的,因为大脑干的近距离和毒性风险.
- 为这些瘤开发安全有效的辐射策略至关重要.
研究的目的:
- 评估混合质子-光子 (PT-XT) 方法的可行性和结果,与单独的质子疗法 (PT) 相比,用于内膜瘤,特别是后腔瘤.
- 评估脑干剂量参数和临床结果,包括症状脑干损伤 (SBI) 和无症状放射性变化 (ARC).
主要方法:
- 在2020年7月至2023年12月期间接受PT或混合PT-XT治疗的内膜瘤患者的回顾性研究.
- 治疗方法取决于瘤与大脑干的距离.
- 在PT和PT-XT组之间比较了剂量计数据和临床结果 (SBI,ARC).
主要成果:
- 在14名患者中,有9名患者患有后腔膜瘤;5名患者接受混合PT-XT,4名患者仅接受PT.
- 混合PT-XT方法提供了75%的PT治疗和其余的光子 (XT).
- 在患者的中位随访时间为22.2个月后,没有观察到有症状的脑干损伤;三名患者有无症状的放射性变化.
结论:
- 根据瘤的位置和脑干关系,定制的计划方法对于尾瘤治疗至关重要.
- 在精心选择的患者中,混合PT-XT方法是可行的,可以实现可接受的目标覆盖率和脑干剂量,迄今为止还没有报告有症状的脑干损伤.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
3.1K
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Healing I: Introduction
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
